- Addex Reports Q3 2022 Financial Results and Provides Corporate Update
- Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022
- Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Addex Increases Issued Share Capital to Create Treasury Shares
- Addex to Present at the Sachs Associates 22nd Annual Biotech in Europe Forum & Baader Investment Conference
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders
- Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call on August 18, 2022
- Addex Completes $4.2 Million Equity Financing
- Addex Raises $4.2 million in Equity Financing
As of last trade
Addex Therapeutics Ltd (APE0:BER) traded at 0.755, 6.34% above its 52-week low of 0.71, set on Nov 09, 2022.
0.71Nov 09 20226.40Dec 16 2021
Markit short selling activity
|Market cap||14.31m USD|
Data delayed at least 15 minutes, as of Nov 29 2022 20:52 GMT.